Serologicals, LINCO, NIST

Premium

Serologicals to Acquire LINCO for $75M to Expand Multiplexing Products Portfolio

Serologicals announced this week that it has made an agreement to acquire LINCO, a life sciences company that focuses on supplying research assays and test kits for the Luminex-based multiplexing platform and other immunoassays.

Under terms of the agreement, Serologicals will pay $64.5 million in cash for the LINCO business, which has 109 employees, plus an additional $10.3 million for the land and buildings currently occupied by LINCO in St. Louis, Mo.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.